News & events

Webinars

Webinars

Previous Webinars

September 27, 2017 11:00am EST

Metrics that Matter: A Guide to Imaging Measurements in Oncology Clinical Trials

Presented by: Fabien Ricard, MD, Medical Director and Catherine Klifa, PhD, Science Liaison

Medical imaging is an integral component of clinical trials in oncology. For each image type, quantifiable information (biomarkers) can be extracted and analyzed to potentially answer questions about tumor types and stage, and to measure any sign of response to treatment. The most common assessment of response to therapy is to measure anatomical changes to the tumor with treatment. Other quantitative imaging measures derived from functional imaging methods provide equally important physiological information about a tumor, including tumor metabolism, vascularity, and cellularity.

What you will learn in this webinar:
– The difference between qualitative and quantitative biomarkers
– Definition of treatment response criteria
– Various types of measurement: morphological and volumetric
– Functional imaging measurements by modality
– Measurements by cancer/treatment type

April 26, 2017 1pm EST

Going Beyond RECIST – How Volumetric and Functional Analysis Can Add Value to Your Oncology Clinical Trials

Hosted by: Median Technologies

Presented by:  Dr. Robert Ford, Clinical Trials Imaging Consulting, LLC

April 26, 2017 at 1pm EST

Three-dimensional, volume-based measurements address some of the inherent limitations of unidimensional RECIST measurements, provide additional measures of efficacy for modern drug classes, and allow for earlier detection of therapeutic response. Early studies indicate that volume-based measurements are both medically meaningful and add value to a clinical trial. Volume measurements can be easily incorporated into existing clinical trial workflows using segmentation software, that also improves trial efficiency and reproducibility.

What you will learn in this webinar:

The Difference between Routine Versus Advanced Endpoints

More about Volume-Based Endpoints and When to Use Them;

Making Volumetric Tumor Measurements:The Nuts and Bolts

Adding Value to Clinical Trials: Are Volumetric Assessments a True Reflection of Drug Response?

Register today!

Register Here

A Case Study: How START accelerates drug development using disruptive image analysis solutions

A Case Study: How START accelerates drug development using disruptive image analysis solutions

Presented by:
Dr. Anthony Tolcher, Director of Clinical Research and Co-Founder START
Leslie Smetzer, Director Phase I Nursing, START

Click here to watch!

Imaging as Endpoints in Oncology Clinical Trials and the FDA Guidelines

Everything you need to know about Imaging as Endpoints in Oncology Clinical Trials and the FDA Guidelines. Presenters: Ciaran Cooper, Head of Business Development – North America, Median Technologies and Dr. Souhil Zaim, Chief Medical Officer, Median Technologies

Click here to watch!

News and events

Cookies help us deliver our services. By using our services, you agree to our use of cookies.